Evidence map›Paper›PMID 42073370›Full record

ArticleLife (Basel, Switzerland)2026

Areej Abuhammad, Fatma Afifi, Nour H Aboalhaija, Mohammed H Kailani, Mutasem O Taha, Tamara Sabri, Zahra Fauri, Ismail Abaza

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Areej AbuhammadDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0003-4978-5059
Fatma AfifiDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Nour H AboalhaijaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.ORCID 0000-0001-9586-4722
Mohammed H KailaniDepartment of Chemistry, School of Science, The University of Jordan, Amman 11942, Jordan.
Mutasem O TahaDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-4453-072X
Tamara SabriDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Zahra FauriDepartment of Chemistry, School of Science, The University of Jordan, Amman 11942, Jordan.
Ismail AbazaDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.

Funding

Deanship of Scientific Research at the University of Jordan 1619
6 · The paper itself

Abstract

The rise in emerging viral outbreaks has intensified the need for novel antiviral therapies and highlighted the untapped potential of natural products. Influenza viruses, particularly avian strains, continue to evolve rapidly, yet the antiviral properties of Jordan's native plants remain largely unexplored. This study focused on avian influenza and screened twelve endemic plant species, using ethanol to selectively extract polar phytochemicals likely to interact with the hydrophilic active site of neuraminidase (NA). Among these,

Indexed as

Arbutus andrachneavian influenzaEricaceaeflavonoidshyperosideneuraminidase inhibition

Identifiers

PMID42073370
PMCPMC13117706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.